STOCK TITAN
  1. Home
  2. Sec-filings
  3. CNA
  4. [Form 4] CNA Financial Corporation Insider Trading Activity

[Form 4] CNA Financial Corporation Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Insperity (NSP) delivered mixed Q2 2025 results.

  • Revenue rose 3% YoY to $1.66 billion on a 1% increase in average work-site employees (WSEEs).
  • Gross profit fell 14% to $223 million; gross profit/WSEE slipped $42 to $240 as health-plan costs jumped 9.6% per covered employee and payroll taxes increased.
  • Operating income swung to a $7 million loss (vs. $23 million profit); net loss was $5 million (-$0.14 EPS) against $18 million profit a year ago.
  • Adjusted EBITDA declined 52% to $32 million; adjusted EPS dropped 70% to $0.26.
  • For the first six months, net income fell 53% to $46 million and operating cash flow was –$522 million.
  • Liquidity: Cash & equivalents decreased to $441 million from $1.04 billion at year-end, mainly due to payroll-tax settlement timing; adjusted liquid resources total $114 million. Revolver borrowings remain $369 million.
  • Stockholders’ equity edged up to $112 million, aided by APIC growth and moderated treasury share purchases.
  • Management attributes margin pressure to large-claim frequency, medical inflation and lower workers’-comp reserve releases. Company is assessing tax changes under the newly enacted “One Big Beautiful Bill Act.”

Insperity (NSP) ha riportato risultati contrastanti nel secondo trimestre 2025.

  • I ricavi sono aumentati del 3% su base annua, raggiungendo 1,66 miliardi di dollari grazie a un incremento dell'1% del numero medio di dipendenti in sede di lavoro (WSEE).
  • Il profitto lordo è calato del 14%, attestandosi a 223 milioni di dollari; il profitto lordo per WSEE è diminuito di 42 dollari, arrivando a 240 dollari, a causa dell'aumento del 9,6% dei costi dei piani sanitari per dipendente coperto e dell'incremento delle tasse sui salari.
  • Il reddito operativo è passato a una perdita di 7 milioni di dollari (rispetto a un utile di 23 milioni); la perdita netta è stata di 5 milioni di dollari (-0,14 dollari per azione) contro un utile di 18 milioni dell'anno precedente.
  • L'EBITDA rettificato è diminuito del 52%, attestandosi a 32 milioni di dollari; l'utile per azione rettificato è sceso del 70%, a 0,26 dollari.
  • Nei primi sei mesi, l'utile netto è calato del 53%, raggiungendo 46 milioni di dollari, mentre il flusso di cassa operativo è stato negativo per 522 milioni di dollari.
  • Liquidità: la liquidità e equivalenti sono scesi a 441 milioni di dollari da 1,04 miliardi a fine anno, principalmente per la tempistica del pagamento delle tasse sui salari; le risorse liquide rettificate ammontano a 114 milioni di dollari. I prestiti sul fido rimangono a 369 milioni di dollari.
  • Il patrimonio netto degli azionisti è leggermente aumentato a 112 milioni di dollari, sostenuto dalla crescita dell’APIC e da un rallentamento negli acquisti di azioni proprie.
  • La direzione attribuisce la pressione sui margini all’aumento della frequenza di grandi sinistri, all’inflazione medica e a una minore liberazione delle riserve per infortuni sul lavoro. L’azienda sta valutando le modifiche fiscali previste dal nuovo “One Big Beautiful Bill Act.”

Insperity (NSP) presentó resultados mixtos en el segundo trimestre de 2025.

  • Los ingresos aumentaron un 3% interanual hasta 1.660 millones de dólares, impulsados por un incremento del 1% en el número promedio de empleados en el sitio de trabajo (WSEE).
  • La ganancia bruta cayó un 14% hasta 223 millones de dólares; la ganancia bruta por WSEE disminuyó 42 dólares hasta 240 dólares debido al aumento del 9,6% en los costos de planes de salud por empleado cubierto y al incremento de los impuestos sobre la nómina.
  • El ingreso operativo pasó a una pérdida de 7 millones de dólares (frente a una ganancia de 23 millones); la pérdida neta fue de 5 millones de dólares (-0,14 dólares por acción) comparado con una ganancia de 18 millones el año anterior.
  • El EBITDA ajustado disminuyó un 52% hasta 32 millones de dólares; la utilidad ajustada por acción cayó un 70% hasta 0,26 dólares.
  • En los primeros seis meses, la utilidad neta cayó un 53% hasta 46 millones de dólares y el flujo de caja operativo fue negativo en 522 millones de dólares.
  • Liquidez: El efectivo y equivalentes bajaron a 441 millones de dólares desde 1.040 millones a fin de año, principalmente debido al momento del pago de impuestos sobre la nómina; los recursos líquidos ajustados suman 114 millones de dólares. Los préstamos revolventes se mantienen en 369 millones de dólares.
  • El patrimonio de los accionistas aumentó ligeramente a 112 millones de dólares, impulsado por el crecimiento de APIC y una moderación en la recompra de acciones propias.
  • La dirección atribuye la presión en los márgenes a la frecuencia de reclamaciones grandes, la inflación médica y menores liberaciones de reservas por compensación laboral. La empresa está evaluando los cambios fiscales bajo la recién promulgada “One Big Beautiful Bill Act.”

Insperity (NSP)는 2025년 2분기에 혼합된 실적을 발표했습니다.

  • 매출은 전년 대비 3% 증가한 16억 6천만 달러를 기록했으며, 평균 현장 근로자 수(WSEE)는 1% 증가했습니다.
  • 총이익은 14% 감소한 2억 2,300만 달러였으며, 건강보험 비용이 피보험자당 9.6% 상승하고 급여세가 증가하면서 WSEE당 총이익은 42달러 줄어 240달러가 되었습니다.
  • 영업이익은 700만 달러 손실로 전환되었으며(전년 동기 2,300만 달러 이익 대비), 순손실은 500만 달러(-주당순손실 0.14달러)로 전년 1,800만 달러 이익에서 적자 전환되었습니다.
  • 조정 EBITDA는 52% 감소한 3,200만 달러였으며, 조정 주당순이익은 70% 감소한 0.26달러였습니다.
  • 상반기 순이익은 53% 감소한 4,600만 달러였고, 영업 현금 흐름은 -5억 2,200만 달러였습니다.
  • 유동성: 현금 및 현금성 자산은 연말 10억 4천만 달러에서 4억 4,100만 달러로 감소했으며, 이는 주로 급여세 정산 시기 때문입니다; 조정된 유동 자원은 1억 1,400만 달러입니다. 신용대출 잔액은 3억 6,900만 달러로 유지되었습니다.
  • 주주 자본은 APIC 증가와 자사주 매입 완화로 인해 1억 1,200만 달러로 소폭 증가했습니다.
  • 경영진은 마진 압박의 원인으로 대형 청구 빈도 증가, 의료비 인플레이션, 산업재해 보상 준비금 감소를 꼽고 있습니다. 회사는 새로 제정된 "One Big Beautiful Bill Act"에 따른 세금 변경 사항을 검토 중입니다.

Insperity (NSP) a publié des résultats mitigés pour le deuxième trimestre 2025.

  • Le chiffre d'affaires a augmenté de 3 % en glissement annuel pour atteindre 1,66 milliard de dollars, porté par une hausse de 1 % du nombre moyen d'employés sur site (WSEE).
  • La marge brute a diminué de 14 % pour s'établir à 223 millions de dollars ; la marge brute par WSEE a baissé de 42 dollars, à 240 dollars, en raison d'une hausse de 9,6 % des coûts des régimes de santé par employé couvert et d'une augmentation des charges sociales.
  • Le résultat d'exploitation est passé à une perte de 7 millions de dollars (contre un bénéfice de 23 millions) ; la perte nette s'élève à 5 millions de dollars (-0,14 $ par action) contre un bénéfice de 18 millions l'année précédente.
  • L'EBITDA ajusté a chuté de 52 % à 32 millions de dollars ; le BPA ajusté a diminué de 70 % pour atteindre 0,26 dollar.
  • Sur les six premiers mois, le résultat net a chuté de 53 % à 46 millions de dollars et les flux de trésorerie opérationnels se sont établis à -522 millions de dollars.
  • Liquidités : les liquidités et équivalents ont diminué à 441 millions de dollars contre 1,04 milliard à la fin de l'année, principalement en raison du calendrier de règlement des taxes sur les salaires ; les ressources liquides ajustées s'élèvent à 114 millions de dollars. Les emprunts sur la ligne de crédit restent à 369 millions de dollars.
  • Les capitaux propres des actionnaires ont légèrement augmenté à 112 millions de dollars, soutenus par la croissance de l’APIC et une réduction des rachats d’actions.
  • La direction attribue la pression sur les marges à la fréquence accrue des sinistres importants, à l’inflation médicale et à une moindre libération des provisions pour accidents du travail. La société évalue les changements fiscaux dans le cadre de la nouvelle loi « One Big Beautiful Bill Act » récemment adoptée.

Insperity (NSP) präsentierte gemischte Ergebnisse für das zweite Quartal 2025.

  • Umsatz stieg im Jahresvergleich um 3 % auf 1,66 Milliarden US-Dollar, bedingt durch einen 1 % Anstieg der durchschnittlichen Mitarbeiterzahl am Arbeitsplatz (WSEE).
  • Bruttogewinn sank um 14 % auf 223 Millionen US-Dollar; der Bruttogewinn pro WSEE fiel um 42 US-Dollar auf 240 US-Dollar, da die Kosten für Gesundheitspläne pro versichertem Mitarbeiter um 9,6 % stiegen und die Lohnsteuern zunahmen.
  • Betriebsergebnis drehte sich in einen Verlust von 7 Millionen US-Dollar (vorher 23 Millionen Gewinn); Nettoverlust betrug 5 Millionen US-Dollar (-0,14 US-Dollar je Aktie) gegenüber einem Gewinn von 18 Millionen im Vorjahr.
  • Das bereinigte EBITDA sank um 52 % auf 32 Millionen US-Dollar; das bereinigte Ergebnis je Aktie fiel um 70 % auf 0,26 US-Dollar.
  • Für die ersten sechs Monate sank der Nettogewinn um 53 % auf 46 Millionen US-Dollar, und der operative Cashflow betrug -522 Millionen US-Dollar.
  • Liquidität: Zahlungsmittel und Zahlungsmitteläquivalente sanken von 1,04 Milliarden auf 441 Millionen US-Dollar, hauptsächlich bedingt durch das Timing der Lohnsteuerzahlungen; bereinigte liquide Mittel betragen 114 Millionen US-Dollar. Revolver-Kreditaufnahmen bleiben bei 369 Millionen US-Dollar.
  • Das Eigenkapital der Aktionäre stieg leicht auf 112 Millionen US-Dollar, begünstigt durch Wachstum des APIC und eine reduzierte Rückkaufaktivität von eigenen Aktien.
  • Das Management führt den Margendruck auf eine erhöhte Häufigkeit großer Schadensfälle, medizinische Inflation und geringere Freisetzungen von Rückstellungen für Arbeitsunfälle zurück. Das Unternehmen prüft steuerliche Änderungen im Rahmen des neu verabschiedeten „One Big Beautiful Bill Act“.
Positive
  • Revenue growth of 3% YoY and 1% increase in average WSEEs signal demand resilience
  • Operating expenses declined 3% YoY, showing cost-containment outside direct benefits
  • Stockholders’ equity improved to $112 million despite the quarterly loss
Negative
  • Net loss of $5 million versus $18 million profit last year
  • Gross profit down 14% due to elevated health-plan and payroll-tax costs
  • Adjusted EBITDA plunged 52%; adjusted EPS fell 70%
  • Cash from operations –$522 million; cash balance more than halved to $441 million
  • Benefit-cost inflation and new federal tax law add forward-looking uncertainty

Insights

TL;DR: Revenue up, margins down; net loss and cash burn overshadow modest top-line growth.

Q2 shows that pricing (+3%) could not offset a 9–10% surge in benefit costs. The gross margin contraction of 140 bps pushed operating income negative and cut adjusted EBITDA in half. Cash outflow reflects timing, but adjusted liquidity of $114 million against $369 million debt leaves little cushion if cost inflation persists. Equity is thin; leverage, though covenant-compliant, is rising in real terms. Near-term upside hinges on benefit-cost stabilization and accelerating WSEE growth; neither is yet evident.

TL;DR: Rising medical claims and new tax law elevate earnings and compliance risk.

Health-insurance volatility added $11 million to YTD costs, and stop-loss protection still leaves NSP exposed to sub-$1 million claims. Workers’ comp reserve releases slowed, suggesting less room for future offsets. The “One Big Beautiful Bill Act” could reprice payroll-tax obligations, adding uncertainty during a leverage-heavy phase. Negative operating cash flow plus seasonal payroll liabilities could pressure the $650 million revolver if claims keep climbing.

Insperity (NSP) ha riportato risultati contrastanti nel secondo trimestre 2025.

  • I ricavi sono aumentati del 3% su base annua, raggiungendo 1,66 miliardi di dollari grazie a un incremento dell'1% del numero medio di dipendenti in sede di lavoro (WSEE).
  • Il profitto lordo è calato del 14%, attestandosi a 223 milioni di dollari; il profitto lordo per WSEE è diminuito di 42 dollari, arrivando a 240 dollari, a causa dell'aumento del 9,6% dei costi dei piani sanitari per dipendente coperto e dell'incremento delle tasse sui salari.
  • Il reddito operativo è passato a una perdita di 7 milioni di dollari (rispetto a un utile di 23 milioni); la perdita netta è stata di 5 milioni di dollari (-0,14 dollari per azione) contro un utile di 18 milioni dell'anno precedente.
  • L'EBITDA rettificato è diminuito del 52%, attestandosi a 32 milioni di dollari; l'utile per azione rettificato è sceso del 70%, a 0,26 dollari.
  • Nei primi sei mesi, l'utile netto è calato del 53%, raggiungendo 46 milioni di dollari, mentre il flusso di cassa operativo è stato negativo per 522 milioni di dollari.
  • Liquidità: la liquidità e equivalenti sono scesi a 441 milioni di dollari da 1,04 miliardi a fine anno, principalmente per la tempistica del pagamento delle tasse sui salari; le risorse liquide rettificate ammontano a 114 milioni di dollari. I prestiti sul fido rimangono a 369 milioni di dollari.
  • Il patrimonio netto degli azionisti è leggermente aumentato a 112 milioni di dollari, sostenuto dalla crescita dell’APIC e da un rallentamento negli acquisti di azioni proprie.
  • La direzione attribuisce la pressione sui margini all’aumento della frequenza di grandi sinistri, all’inflazione medica e a una minore liberazione delle riserve per infortuni sul lavoro. L’azienda sta valutando le modifiche fiscali previste dal nuovo “One Big Beautiful Bill Act.”

Insperity (NSP) presentó resultados mixtos en el segundo trimestre de 2025.

  • Los ingresos aumentaron un 3% interanual hasta 1.660 millones de dólares, impulsados por un incremento del 1% en el número promedio de empleados en el sitio de trabajo (WSEE).
  • La ganancia bruta cayó un 14% hasta 223 millones de dólares; la ganancia bruta por WSEE disminuyó 42 dólares hasta 240 dólares debido al aumento del 9,6% en los costos de planes de salud por empleado cubierto y al incremento de los impuestos sobre la nómina.
  • El ingreso operativo pasó a una pérdida de 7 millones de dólares (frente a una ganancia de 23 millones); la pérdida neta fue de 5 millones de dólares (-0,14 dólares por acción) comparado con una ganancia de 18 millones el año anterior.
  • El EBITDA ajustado disminuyó un 52% hasta 32 millones de dólares; la utilidad ajustada por acción cayó un 70% hasta 0,26 dólares.
  • En los primeros seis meses, la utilidad neta cayó un 53% hasta 46 millones de dólares y el flujo de caja operativo fue negativo en 522 millones de dólares.
  • Liquidez: El efectivo y equivalentes bajaron a 441 millones de dólares desde 1.040 millones a fin de año, principalmente debido al momento del pago de impuestos sobre la nómina; los recursos líquidos ajustados suman 114 millones de dólares. Los préstamos revolventes se mantienen en 369 millones de dólares.
  • El patrimonio de los accionistas aumentó ligeramente a 112 millones de dólares, impulsado por el crecimiento de APIC y una moderación en la recompra de acciones propias.
  • La dirección atribuye la presión en los márgenes a la frecuencia de reclamaciones grandes, la inflación médica y menores liberaciones de reservas por compensación laboral. La empresa está evaluando los cambios fiscales bajo la recién promulgada “One Big Beautiful Bill Act.”

Insperity (NSP)는 2025년 2분기에 혼합된 실적을 발표했습니다.

  • 매출은 전년 대비 3% 증가한 16억 6천만 달러를 기록했으며, 평균 현장 근로자 수(WSEE)는 1% 증가했습니다.
  • 총이익은 14% 감소한 2억 2,300만 달러였으며, 건강보험 비용이 피보험자당 9.6% 상승하고 급여세가 증가하면서 WSEE당 총이익은 42달러 줄어 240달러가 되었습니다.
  • 영업이익은 700만 달러 손실로 전환되었으며(전년 동기 2,300만 달러 이익 대비), 순손실은 500만 달러(-주당순손실 0.14달러)로 전년 1,800만 달러 이익에서 적자 전환되었습니다.
  • 조정 EBITDA는 52% 감소한 3,200만 달러였으며, 조정 주당순이익은 70% 감소한 0.26달러였습니다.
  • 상반기 순이익은 53% 감소한 4,600만 달러였고, 영업 현금 흐름은 -5억 2,200만 달러였습니다.
  • 유동성: 현금 및 현금성 자산은 연말 10억 4천만 달러에서 4억 4,100만 달러로 감소했으며, 이는 주로 급여세 정산 시기 때문입니다; 조정된 유동 자원은 1억 1,400만 달러입니다. 신용대출 잔액은 3억 6,900만 달러로 유지되었습니다.
  • 주주 자본은 APIC 증가와 자사주 매입 완화로 인해 1억 1,200만 달러로 소폭 증가했습니다.
  • 경영진은 마진 압박의 원인으로 대형 청구 빈도 증가, 의료비 인플레이션, 산업재해 보상 준비금 감소를 꼽고 있습니다. 회사는 새로 제정된 "One Big Beautiful Bill Act"에 따른 세금 변경 사항을 검토 중입니다.

Insperity (NSP) a publié des résultats mitigés pour le deuxième trimestre 2025.

  • Le chiffre d'affaires a augmenté de 3 % en glissement annuel pour atteindre 1,66 milliard de dollars, porté par une hausse de 1 % du nombre moyen d'employés sur site (WSEE).
  • La marge brute a diminué de 14 % pour s'établir à 223 millions de dollars ; la marge brute par WSEE a baissé de 42 dollars, à 240 dollars, en raison d'une hausse de 9,6 % des coûts des régimes de santé par employé couvert et d'une augmentation des charges sociales.
  • Le résultat d'exploitation est passé à une perte de 7 millions de dollars (contre un bénéfice de 23 millions) ; la perte nette s'élève à 5 millions de dollars (-0,14 $ par action) contre un bénéfice de 18 millions l'année précédente.
  • L'EBITDA ajusté a chuté de 52 % à 32 millions de dollars ; le BPA ajusté a diminué de 70 % pour atteindre 0,26 dollar.
  • Sur les six premiers mois, le résultat net a chuté de 53 % à 46 millions de dollars et les flux de trésorerie opérationnels se sont établis à -522 millions de dollars.
  • Liquidités : les liquidités et équivalents ont diminué à 441 millions de dollars contre 1,04 milliard à la fin de l'année, principalement en raison du calendrier de règlement des taxes sur les salaires ; les ressources liquides ajustées s'élèvent à 114 millions de dollars. Les emprunts sur la ligne de crédit restent à 369 millions de dollars.
  • Les capitaux propres des actionnaires ont légèrement augmenté à 112 millions de dollars, soutenus par la croissance de l’APIC et une réduction des rachats d’actions.
  • La direction attribue la pression sur les marges à la fréquence accrue des sinistres importants, à l’inflation médicale et à une moindre libération des provisions pour accidents du travail. La société évalue les changements fiscaux dans le cadre de la nouvelle loi « One Big Beautiful Bill Act » récemment adoptée.

Insperity (NSP) präsentierte gemischte Ergebnisse für das zweite Quartal 2025.

  • Umsatz stieg im Jahresvergleich um 3 % auf 1,66 Milliarden US-Dollar, bedingt durch einen 1 % Anstieg der durchschnittlichen Mitarbeiterzahl am Arbeitsplatz (WSEE).
  • Bruttogewinn sank um 14 % auf 223 Millionen US-Dollar; der Bruttogewinn pro WSEE fiel um 42 US-Dollar auf 240 US-Dollar, da die Kosten für Gesundheitspläne pro versichertem Mitarbeiter um 9,6 % stiegen und die Lohnsteuern zunahmen.
  • Betriebsergebnis drehte sich in einen Verlust von 7 Millionen US-Dollar (vorher 23 Millionen Gewinn); Nettoverlust betrug 5 Millionen US-Dollar (-0,14 US-Dollar je Aktie) gegenüber einem Gewinn von 18 Millionen im Vorjahr.
  • Das bereinigte EBITDA sank um 52 % auf 32 Millionen US-Dollar; das bereinigte Ergebnis je Aktie fiel um 70 % auf 0,26 US-Dollar.
  • Für die ersten sechs Monate sank der Nettogewinn um 53 % auf 46 Millionen US-Dollar, und der operative Cashflow betrug -522 Millionen US-Dollar.
  • Liquidität: Zahlungsmittel und Zahlungsmitteläquivalente sanken von 1,04 Milliarden auf 441 Millionen US-Dollar, hauptsächlich bedingt durch das Timing der Lohnsteuerzahlungen; bereinigte liquide Mittel betragen 114 Millionen US-Dollar. Revolver-Kreditaufnahmen bleiben bei 369 Millionen US-Dollar.
  • Das Eigenkapital der Aktionäre stieg leicht auf 112 Millionen US-Dollar, begünstigt durch Wachstum des APIC und eine reduzierte Rückkaufaktivität von eigenen Aktien.
  • Das Management führt den Margendruck auf eine erhöhte Häufigkeit großer Schadensfälle, medizinische Inflation und geringere Freisetzungen von Rückstellungen für Arbeitsunfälle zurück. Das Unternehmen prüft steuerliche Änderungen im Rahmen des neu verabschiedeten „One Big Beautiful Bill Act“.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Stone Susan Ann
(Last) (First) (Middle)
151 N. FRANKLIN ST.
(Street)
CHICAGO IL 60606
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CNA FINANCIAL CORP [ CNA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & General Counsel
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/31/2025 F(1) 13,614 D $44.26 55,165 D
Common Stock 07/31/2025 F(2) 10,834 D $44.26 44,331 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The Company's Incentive Compensation Plan (as amended and restated as of January 1, 2020) permits the withholding of shares of common stock to satisfy tax withholding obligations of the participants. These shares were previously reported on March 19, 2024. Due to retirement and in accordance with the award terms, the vesting date was accelerated to July 31, 2025.
2. The Company's Incentive Compensation Plan (as amended and restated as of January 1, 2020) permits the withholding of shares of common stock to satisfy tax withholding obligations of the participants. These shares were previously reported on March 18, 2025. Due to retirement and in accordance with the award terms, the vesting date was accelerated to July 31, 2025.
Remarks:
Stathy Darcy by Power of Attorney for Susan A. Stone 08/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

How did Insperity’s Q2 2025 revenue compare to Q2 2024?

Revenue rose 3% to $1.66 billion, driven by modest WSEE growth and 3% higher pricing.

Why did Insperity report a net loss in Q2 2025?

A 9.6% rise in medical benefits and higher payroll taxes compressed gross profit, turning a $23 million prior-year operating profit into a $7 million loss.

What happened to Insperity’s cash position during the quarter?

Cash and equivalents fell to $441 million from $1.04 billion at year-end, mainly due to payroll-tax timing; adjusted liquidity stands at $114 million.

How much debt does Insperity carry?

The company has $369 million outstanding on its $650 million revolving credit facility, plus a $1 million letter of credit.

What is the impact of the new “One Big Beautiful Bill Act”?

Management is still evaluating the law; no financial adjustments were recorded in Q2 2025, but future deferred-tax balances may change.

Did Insperity repurchase shares in Q2 2025?

Yes, it repurchased 45,000 shares and withheld 179,867 shares for tax purposes, leaving 1.41 million shares authorized under its buyback program.
Stock CNA logo
CNA Financial

NYSE:CNA

CNA Rankings

#1026 Ranked by Market Cap
#814 Ranked by Dividends

CNA Latest News

Jul 15, 2025
CNA Financial to Report Second Quarter 2025 Results on August 4
Jun 18, 2025
CNA Launches Cardinal E&S℠, A CNA Brand to Deepen Commitment to Excess & Surplus Market
May 5, 2025
CNA FINANCIAL ANNOUNCES FIRST QUARTER 2025 NET INCOME OF $1.00 PER SHARE AND CORE INCOME OF $1.03 PER SHARE
May 5, 2025
LOEWS CORPORATION REPORTS NET INCOME OF $370 MILLION FOR THE FIRST QUARTER OF 2025
Apr 15, 2025
CNA Financial to Report First Quarter 2025 Results on May 5

CNA Latest SEC Filings

Jul 7, 2025
[8-K] CNA Financial Corporation Reports Material Event
Jul 1, 2025
[Form 4] CNA Financial Corporation Insider Trading Activity
Jul 1, 2025
[144] CNA Financial Corporation SEC Filing

CNA Stock Data

11.92B
269.40M
0.39%
99.3%
0.36%
Insurance - Property & Casualty
Fire, Marine & Casualty Insurance
Link
United States
CHICAGO